Purchase Order 140G0220P0237
- Not listed
- The U.S. government has awarded a firm-fixed-price delivery order contract to Illumina, Inc., a manufacturer of sequencing and analysis solutions, for a MiSeq Silver Support Plan. The $14,562.64 contract, which has no set-aside designation, was awarded by the Midwest Area division of a civilian federal agency. The support plan is intended to provide maintenance and services for the MiSeq sequencing system used for laboratory equipment, consumables, and services. Illumina has previously...
- This is a $16,198 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq Silver Support Plan with an ultimate completion date of February 5, 2026. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has been awarded previous prime contracts and subcontracts by federal...
- This federal contract award is a $12,888.97 firm fixed price delivery order placed against the U.S. Department of Agriculture's (USDA) existing Illumina Blanket Purchase Agreement (BPA) contract. The award is for a MiSeq Silver Support Plan (part #20019983) to support the agency's genomic sequencing needs. Illumina, Inc., the prime contractor and manufacturer of the MiSeq sequencing platform, is providing the maintenance and support services. This delivery order does not include any set-aside...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract provides a MiSeq Silver Support Plan with a ceiling value of $13,250.00 and an ultimate completion date of January 2, 2021. Illumina has a long history of providing sequencing systems and related products and services to support research and diagnostics across...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $401,962.00 contract is for a MISEQ SILVER SUPPORT PLAN, with a completion date of November 25, 2024. Illumina has previously received prime federal contracts from agencies such as the National Institutes of Health, Centers for Disease Control and Prevention,...
- This federal contract award to Illumina, Inc. is for the provision of a MiSeq Silver Support Plan, which includes the supply of genetic analysis products and services for a one-year period from December 1, 2020 to November 30, 2021. The contract, awarded on a firm fixed price basis with no set-aside, has a ceiling value of $12,888.97. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing similar products and support services to various...
- This federal contract award is for a Delivery Order under the MiSeq Silver Support Plan provided by Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $15,145.13 firm fixed price contract was awarded on May 26, 2020 by a Civilian federal agency, the Pacific West Area, to support the agency's Laboratory Equipment, Consumables and Services program. The contract includes full coverage for parts, labor, travel, reagent replacement, preventative...
- This federal contract award is for a MiSeq Silver Support Plan from Illumina, Inc., a manufacturer of sequencing and genomic analysis equipment. The $12,587.50 firm fixed-price purchase order was awarded by the Midwest Area of a civilian federal agency (ID 1200|12H2|VPARSFRIIDMWA-A) under an existing Blanket Purchase Agreement (AG-32SC-B-14-0005) for a one-year period of performance from October 22, 2019 to October 21, 2020. The award supports the agency's use of the MiSeq sequencing system,...
- The U.S. government agency awarded a $12,888.96 firm fixed-price purchase order contract to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The "MISEQ SILVER SUPPORT PLAN" contract, which does not have a set-aside designation, is for the provision of maintenance and support services for the agency's MiSeq sequencing platform. Illumina, Inc., the prime contractor, is a for-profit manufacturer of goods headquartered in San...
- This federal contract award is for a MiSeq Silver Support Plan from Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $12,875 firm fixed price purchase order was issued by a civilian federal agency, with a performance location in Calverton, Maryland. The contract includes full coverage for parts, labor, and travel as well as reagent replacement upon hardware failures for the MiSeq sequencing system. Illumina has a history of providing sequencing products and...
This is a $84,332.60 firm fixed price purchase order contract awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc. for a MiSeq Silver Support Plan. The contract has an ultimate completion date of August 14, 2026 and was awarded on August 15, 2020. This award does not have a set-aside designation. Illumina, a manufacturer of sequencing and array-based solutions, has previously received federal contracts and subcontracts from agencies like NIH, CDC, USDA, and VA to provide genomic sequencing systems, reagents, and related services. The MiSeq Silver Support Plan is likely a maintenance and support service for Illumina's MiSeq DNA sequencing platform, which has been used by the federal government for various research and diagnostic applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $15.5k | 8/26/24 | |
| P00003 | Exercise an Option | $14.9k | 7/11/23 | |
| P00002 | Exercise an Option | $14.3k | 7/7/22 | |
| P00001 | Exercise an Option | $13.8k | 7/28/21 | |
| Not listed | Not listed | $17.8k | 7/23/20 |